Bank of America Corp DE grew its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 97.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,239,982 shares of the company's stock after acquiring an additional 613,505 shares during the period. Bank of America Corp DE owned 0.95% of Surgery Partners worth $14,781,000 as of its most recent SEC filing.

• Here’s Why Surgery Partners Could Be the Next Hot Takeover

A number of other hedge funds have also modified their holdings of the stock. Janus Henderson Group PLC raised its position in Surgery Partners by 3.8% during the fourth quarter. Janus Henderson Group PLC now owns 13,537,984 shares of the company's stock valued at $209,162,000 after acquiring an additional 501,401 shares in the last quarter. Pentwater Capital Management LP grew its stake in shares of Surgery Partners by 66.9% in the third quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company's stock worth $252,777,000 after acquiring an additional 4,681,000 shares during the last quarter. UBS Group AG raised its position in shares of Surgery Partners by 111.4% during the fourth quarter. UBS Group AG now owns 7,803,974 shares of the company's stock valued at $120,571,000 after buying an additional 4,113,052 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Surgery Partners by 7.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company's stock valued at $63,131,000 after acquiring an additional 389,831 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in Surgery Partners by 528.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,959,686 shares of the company's stock valued at $30,277,000 after buying an additional 1,647,714 shares during the period.

Wall Street Analyst Weigh In

SGRY has been the topic of several recent analyst reports. Benchmark reissued a "buy" rating on shares of Surgery Partners in a report on Tuesday, August 11th. Zacks Research cut Surgery Partners from a "strong-buy" rating to a "hold" rating in a report on Monday, August 10th. Cantor Fitzgerald reissued an "overweight" rating and issued a $18.00 price objective on shares of Surgery Partners in a research note on Tuesday, August 11th. Royal Bank Of Canada decreased their target price on Surgery Partners from $20.00 to $19.00 and set an "outperform" rating on the stock in a report on Tuesday, August 11th. Finally, TD Cowen raised their target price on Surgery Partners from $17.00 to $19.00 and gave the company a "buy" rating in a research note on Tuesday, August 11th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $19.45.

• Surgery Partners feeling no pinch from macroeconomic weakness

Check Out Our Latest Research Report on Surgery Partners

Surgery Partners Trading Up 4.2%

Surgery Partners stock opened at $14.52 on Friday. The stock has a 50-day simple moving average of $15.57 and a 200 day simple moving average of $14.39. The stock has a market capitalization of $1.90 billion, a P/E ratio of -20.74, a PEG ratio of 3.78 and a beta of 1.91. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. Surgery Partners, Inc. has a 52 week low of $11.41 and a 52 week high of $23.79.

• Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.04. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.The company had revenue of $848.90 million during the quarter, compared to analysts' expectations of $830.03 million. During the same period last year, the firm posted $0.17 earnings per share. The business's revenue was up 2.7% on a year-over-year basis. Analysts expect that Surgery Partners, Inc. will post 0.25 earnings per share for the current year.

Insider Activity at Surgery Partners

In other Surgery Partners news, Director Teresa Deluca bought 10,000 shares of the firm's stock in a transaction on Tuesday, August 18th. The shares were purchased at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the transaction, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.00% of the company's stock.

Surgery Partners Company Profile

(Free Report)

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.

Read More

• Five stocks we like better than Surgery Partners
• Blueprint for a Boom: SEC Clears the Crypto Runway
• Ross Stores Just Flipped the Off-Price Retail Story After TJX's Marmaxx Miss
• Advance Auto Parts Plunged, But Its Turnaround Is Still Working
• Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Surgery Partners Right Now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here